My average is well under 10c so not purchase price, but thanks for assuming and commenting.
Based on being in the right sector, great product, the large at the time cap raise at 18c, forward potential, quality management, old management selling which has caused SP decline, strong health and COVID tailwinds, joining health frameworks allowing for less tendering, glowing endorsements from users and upper hospital management, numerous awards.
Ann: Q1 FY2021 Business Update and Appendix 4C, page-76
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
